Levamlodipine Gentisate
龙胆酸左旋氨氯地平
Report date: 2026/03/30 17:02:26
Base Information
Drug NameLevamlodipine Gentisate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSk Chemicals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAhn-Gook Pharmaceutical Co LtdSk Chemicals Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A